View Document Preview and Link
Document Date: 2011-07-26 06:58:59 Open Document File Size: 29,03 KB Share Result on Facebook
City Tokyo / DEERFIELD / / Company Merck & Co. Inc. / Astellas Pharma Inc. / Merck / Schering-Plough / 4About Astellas Astellas US LLC / Merck Sharp & Dohme Corp. / Astellas US LLC / Cardiome Pharma Corp. / / Country Mexico / Norway / United States / Iceland / Canada / / Event FDA Phase / M&A / Business Partnership / / Facility Astellas WHITEHOUSE STATION / / IndustryTerm animal health products / health solutions / pharmaceutical / healthcare / pharmaceutical industry regulation / pharmaceutical products / / MedicalCondition ventricular tachycardias / sinus node dysfunction / severe bradycardia / acute atrial fibrillation / hypersensitivity / ventricular arrhythmia / Hypotension / congestive heart failure / valvular heart disease / atherosclerosis / heart block / dysgeusia / aortic stenosis / onset atrial fibrillation / acute coronary syndrome / myocardial infarction / heart failure / Atrial fibrillation / / MedicalTreatment cardiac surgery / surgery / biologic therapies / / Organization European Union / Securities and Exchange Commission / / Person Masao Yoshida / Michael Mendelsohn / Ian McConnell / / / Position President / franchise head / cardiovascular and atherosclerosis research / Global Category Leader / global healthcare leader / CEO / senior vice president / franchise head / Private / / Product European Union / BRINAVESS™ (vernakalant) / / ProvinceOrState New Jersey / Illinois / / URL www.sec.gov / www.merck.com / www.astellas.us / / SocialTag